References
- Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596 https://doi.org/10.1056/NEJMra023144
- Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-555 https://doi.org/10.1016/S0025-6196(12)61493-1
- Rodney HF, Dubry SW. Amyloid heart disease. Prog Cardiovasc Dis 2010;52:347-361 https://doi.org/10.1016/j.pcad.2009.11.007
- Falk RH. Diagnosis and management of the cardiac amyloidosis. Circulation 2005;112:2047-2060 https://doi.org/10.1161/CIRCULATIONAHA.104.489187
- Pellikka PA, Holmes Jr DR, Edwards WD, et al. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 1988;148:662-666 https://doi.org/10.1001/archinte.1988.00380030168027
- Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 2010;122:900-909 https://doi.org/10.1161/CIRCULATIONAHA.109.924167
- Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006;92:343-349
- Syed IS, Glockner JF, DaLi F, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Cardiovasc Im 2010;3:155-164
- Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51:1022-1030 https://doi.org/10.1016/j.jacc.2007.10.049
- Austin BA, Wilson Tang WH, Rodriguez R, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. J Am Coll Cardiol 2009;12:1369-1377
- Bellavia D, Pellikka PA, Abraham TP, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol 2008;101:1039- 1045 https://doi.org/10.1016/j.amjcard.2007.11.047
- Cummings KW, Bhalla S, Javidan-Nejad C, Bierhals AJ, Gutierrez FR, Woodard PK. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR Imaging. Radiographics 2009;29:89-103 https://doi.org/10.1148/rg.291085052
- Cerqueira MD, Weissman NJ, Diilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association. Circulation 2002;105:539-542 https://doi.org/10.1161/hc0402.102975
- Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193 https://doi.org/10.1161/01.CIR.0000152819.97857.9D
- Ruberg FL, Appelhaum E, Davidoff R, et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 2009;103:544- 549 https://doi.org/10.1016/j.amjcard.2008.09.105
- Mekinian A, Lions C, Leleu X, et al. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. J Am Med 2010;123:864-868 https://doi.org/10.1016/j.amjmed.2010.03.022
- Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT and Giuliani ER. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981;63:188-196 https://doi.org/10.1161/01.CIR.63.1.188
- Di Bella G, Minutoli F, Mazzeo A, et al. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol 2010;195:394-399 https://doi.org/10.2214/AJR.09.3721
- Berk JL, Keane J, Seldin DC. Persistent pleural effusions in primary systemic amyloidosis - etiology and prognosis. Chest 2003;124;969-977 https://doi.org/10.1378/chest.124.3.969
- Falk RH, Plehn JF, Deering T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987;59:418-422 https://doi.org/10.1016/0002-9149(87)90948-9
- Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998;136:824-830 https://doi.org/10.1016/S0002-8703(98)70127-9
- Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med 1973;132:522-523 https://doi.org/10.1001/archinte.1973.03650100040007
- Migrino RQ, Christenson R, zabo A, Bright M, Truran S, Hari P. Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys 2009;9:5